PLOS ONE RESEARCH ARTICLE Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study 1,2 1 3 1 1 Beatriz GalatasID *, Hoticha Nhantumbo , Rodolfo Soares , Helder Djive , Ilda Murato , Wilson Simone1, Eusebio Macete1,4, N. Regina Rabinovich2,5, Pedro Alonso1,2, Baltazar Candrinho6, Francisco Sau te1, Pedro Aide1,7, KhaÂtia Munguambe1,8 a1111111111 a1111111111 1 Centro de InvestigacËão em SauÂde de ManhicËa, Maputo, Mozambique, 2 ISGlobal, Hospital ClõÂnicÐ a1111111111 Universitat de Barcelona, Barcelona, Spain, 3 Center for International Studies (CEI-IUL), Lisbon, Portugal, a1111111111 4 National Directorate of Health, Ministry of Health, Maputo, Mozambique, 5 Harvard T.H. Chan School of a1111111111 Public Health, Boston, Massachusetts, United States of America, 6 National Malaria Control Programme (NMCP), Ministry of Health, Maputo, Mozambique, 7 National Institute of Health, Ministry of Health, Maputo, Mozambique, 8 Faculdade de Medicina, Universidade Eduardo Mondlane (UEM), Maputo, Mozambique *
[email protected] OPEN ACCESS Citation: Galatas B, Nhantumbo H, Soares R, Djive Abstract H, Murato I, Simone W, et al. (2021) Community acceptability to antimalarial mass drug administrations in Magude district, Southern Background Mozambique: A mixed methods study. PLoS ONE 16(3): e0249080. https://doi.org/10.1371/journal. This study aimed to capture the acceptability prior to, during and after the implementation of pone.0249080 the first year of MDA rounds conducted under the Magude project, a malaria elimination Editor: Luzia Helena Carvalho, Instituto Rene project in southern Mozambique. Rachou, BRAZIL Received: August 27, 2020 Methods Accepted: March 10, 2021 This was a mixed-methods study, consisting of focus group discussions (FGDs) prior to the Published: March 23, 2021 implementation of MDA rounds (September 2015), non-participant observations (NPOs) conducted during the MDA rounds (November 2015 ±beginning of February 2016), and Copyright: © 2021 Galatas et al.